Skip to content
Dx

ICD-10-PCS 2027 procedure code

XW133E7Transfusion of Hyperimmune Globulin into Peripheral Vein, Percutaneous Approach, New Technology Group 7

✓ Valid for 2027

Short description: Transfuse Hyprimun Globln in Periph Vein, Perc, New Tech 7

Code last changed in FY2022 (effective October 1, 2021). Source: official FY2027 ICD-10-PCS release from CMS. Page updated September 29, 2026. About our data

About XW133E7

XW133E7 is the ICD-10-PCS code for a transfusion procedure on the peripheral vein using a percutaneous approach with hyperimmune globulin (qualifier: new technology group 7). In ICD-10-PCS, transfusion means putting in blood or blood products.

For a different body part, codes include XW143E7 (central vein).

It doesn't appear in the MS-DRG procedure index, so on its own it doesn't change the DRG assignment.

It was added in FY2022, effective October 1, 2021.

What each character means

1. Section
XNew Technology
2. Body System
WAnatomical Regions
3. Operation
1Transfusion

Putting in blood or blood products

4. Body Part
3Peripheral Vein
5. Approach
3Percutaneous

Entry, by puncture or minor incision, of instrumentation through the skin or mucous membrane and any other body layers necessary to reach the site of the procedure

6. Device / Substance / Technology
EHyperimmune Globulin

Includes: Anti-SARS-CoV-2 hyperimmune globulin; HIG (hyperimmune globulin), for COVID-19 treatment; hIVIG (hyperimmune intravenous immunoglobulin), for COVID-19 treatment; Hyperimmune intravenous immunoglobulin (hIVIG), for COVID-19 treatment; IGIV-C, for COVID-19 treatment

7. Qualifier
7New Technology Group 7

Other versions of this procedure

Different body part

Code history

  1. 2016
  2. 2017
  3. 2018
  4. 2019
  5. 2020
  6. 2021
  7. 2022
  8. 2023
  9. 2024
  10. 2025
  11. 2026
  12. 2027
  • FY2022 (effective 10/1/2021): Added
  • No changes since FY2022.

Common questions about XW133E7

Is XW133E7 a valid ICD-10-PCS code for 2027?

Yes. XW133E7 is valid for inpatient procedures from October 1, 2026 through September 30, 2027.